Chlamydia: Resources for Healthcare Providers - American Sexual Health Association

Chlamydia: Resources for Healthcare Providers

Improving Chlamydia Screening Rates:
Engaging Providers, Patients and Payers

June 21, 2016
Washington, DC 

The presentations on this page are from a meeting convened by the American Sexual Health Association in June 2016 titled Improving Chlamydia Screening Rates: Engaging Providers, Patients and Payers

The meeting brought together experts in sexual health and sexually transmitted infection (STI) prevention along with relevant stakeholders in the health insurance system to discuss strategies to improve chlamydia screening rates among young, sexually active women.

Chlamydia is the most frequently reported bacterial STI in the United States, with 1,441,789 cases reported to CDC from 50 states and the District of Columbia in 2014. Because much goes unreported, CDC estimates 2.86 million infections occur annually. Untreated chlamydia can cause pelvic inflammatory disease, leading to infertility or ectopic pregnancy. However, because it is often without symptoms, especially in the early stages, many women don’t realize they are infected. On average, young women go without treatment for a year.

Annual routine screening of sexually active women is the best way to identify and subsequently treat women, since up to 75% of women with chlamydia have no symptoms. Inexpensive, highly sensitive and specific screening tests are available, and chlamydia can be treated inexpensively. Screening for chlamydia is included as a HEDIS  (Health Plan Employer Data and Information Set) measure since 2000. This HEDIS indicator measures the proportion of sexually active females between the ages of 15 and 24 who were screened for chlamydial infection annually.

Click the title of each presentation to access a PDF of the slide set.

Chlamydia: An Overview

Elizabeth Torrone, MSPH, PhD, Epidemiologist
Division of STD Prevention, Centers for Disease Control and Prevention

Outreach to the Private Sector

Alyson Kristensen, MPH, Director
National Chlamydia Coalition

Chlamydia Screening Measurement

Sepheen Byron, MHS, Director of Performance Measurement
National Committee for Quality Assurance

Working with Health Departments, Community Members, Health Plans

Candy Hadsall, RN, STD Nurse Specialist, Infertility Prevention Project Coordinator
Minnesota Department of Health

Health Plans in Minnesota Partner on Chlamydia Screening

Patty Graham, Senior Quality Consultant

Ochsner Population Health

Susan Montz, BSN, MBA Director Accountable Care Organizations Performance Improvement
Ochsner Health System

Creating and Disseminating Novel Approaches

Deborah Arrindell, Vice President, Health Policy
American Sexual Health Association

Back to Top